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ABSTRACT
In cell culture, a partially purified commercial preparation of phospholipase C (PLC) from
Clostridium welchii inhibited fusion of myoblasts at concentrations of 12-50 µg per ml . At
lower concentrations, PLC-treated cultures were indistinguishable from controls, and at
concentrations above 100 µg per ml, PLC-treated cells detached from their substrates . The
effect was reversible and fusion resumed approximately one cell cycle time after removal of
the enzyme. Neither the percent of cells in the mitotic cycle nor the duration of the different
phases of the cycle were altered by PLC at concentrations which inhibited fusion . Cell
motility was not reduced by the enzyme . Unfused, PLC-treated myoblasts were virtually
indistinguishable in ultrastructure from untreated cells just before fusion . In the presence of
PLC, mononucleated myogenic cells did not synthesize thick (150 A) filaments. Treatment
of culture medium with insolubilized commercial PLC did not abolish the capacity of the
medium to support myogenesis. Chondrocytes treated with PLC divided repeatedly but
failed to synthesize metachromatic matrix and failed to incorporate labeled sulfate into
chondroitin sulfate. PLC was further purified by chromatography on Sephadex G-100 . The
resulting preparation was free of detectable protease, yielded one band on SDS-acrylamide
gel electrophoresis, and displayed all of the biological activities of the less pure material .
INTRODUCTION
Through largely indirect evidence, the cell surface
has been implicated in the control of cellular
differentiation. Many types of cells do not express
their specialized properties in isolation from other
cells but appear to require surface-to-surface con-
tact in order to carry out their differentiated func-
tions. Myoblasts and chondrocytes are examples of
such cell types. In order to form skeletal muscle
fibers, myoblasts must contact each other and then
fuse to form multinucleated myotubes (14, 16, 27,
34) . Fusion occurs only during the G l (or Go)
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phase of the cell cycle (3, 28), apparently requires
the presence of calcium (29), and may require a
mitosis to be expressed (3, 25). Chondrocytes, in
multiplying cultures, first begin to deposit extra-
cellular cartilage matrix in areas between cells
where there is close surface-to-surface contact (35) .
The molecular basis for surface interaction or "cell
recognition" is unknown . It has been proposed
that enzymes on the cell periphery are involved in
surface interactions (32) . In this report we describe
initial studies which may lead to an identification
107of some of the molecular species involved in the
cell recognition phenomena preceding fusion of
myoblasts or deposition of matrix by chondro-
cytes. We have found that phospholipase C (PLC)
reversibly inhibits fusion of myoblasts without
significantly altering cell surface activities asso-
ciated with mitosis or cell movement. PLC also
suppresses cartilage matrix synthesis by chondro-
cytes. The antidifferentiation effect of PLC is
similar to that of 5-bromodeoxyuridine (1, 4, 36)
and may result from the liberation of a class of
proteins from the cell surface.
MATERIALS AND METHODS
Cell Culture
Myogenic cells and vertebral chondrocytes were
prepared from 11-day chick embryos as described
previously (25). The cells were plated at an initial
density of 0.33 X 106 per ml of medium (Eagle's
Minimal Essential Medium (MEM), 7.8 parts; horse
serum, 1 .0 part; embryo extract, 1 .0 part; penicillin-
streptomycin solution, 0.1 part; fungizone, 0.1 part).
In all experiments, 0 .5 X 106 cells were grown at
37.5'C on gelatin- or plasma clot-coated 22-mm square
cover slips in 35-mm Petri dishes in a water-saturated
atmosphere containing 5% CO2 in air. The medium
was changed on the day after initiation of the cultures
and every other day thereafter . At appropriate times
myogenic cell cultures were washed once with Earle's
balanced salt solution (BSS), fixed in ethanol : forma-
lin: acetic acid (20:2 :1), and stained with Ehrlich's
hematoxylin. Chondrocyte cultures were fixed and
stained with toluidine blue according to the procedure
of Danes and Bearn (7).
Electron Microscopy
Cultures were rinsed with BSS and fixed for 90 min
with 2.5% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.2, containing 0.01 M CaC12. They were
then rinsed in 0.1 M sucrose in the same buffer and
were postfixed for 60 min in 17 0 OsO4, also in caco-
dylate buffer. Still in the culture dishes, the tissues
were passed through graded ethanols and were em-
bedded in Epon. Sections were stained with uranyl
acetate and lead citrate and were examined in a
Philips 200 microscope.
Autoradiography
Myogenic cells were exposed to [methyl-3H]thymi-
dine (New England Nuclear, Boston, Mass., sp act
6.7 Ci per mmol) at a concentration of 1 .0 ltCi per ml
of culture medium. For cell cycle determinations,
cultures were exposed to the isotope for 15 min on the
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second day in vitro. At the end of the 15-min period,
several cultures were fixed immediately . The remain-
ing dishes were washed three times with BSS, and
fresh medium containing 0.2 mM unlabeled thymi-
dine was added. Several cultures were fixed every 2 h
thereafter. PLC at a concentration of 25 µg per ml
had been present in the medium of half the cultures
for 24 h before the addition of labeled thymidine . This
concentration was maintained throughout the deter-
mination of the cell cycle time. In another experi-
ment, [methyl-3H]thymidine was present during the
second 24 h of a 2-day exposure to PLC . PLC and
labeled thymidine were then removed and fresh
medium containing unlabeled thymidine was added.
Cultures were fixed after incubation for 12 or 24 h in
unlabeled medium. In all cases, autoradiograms were
prepared by dipping slide-mounted cover slips in
Kodak NTB3 emulsion diluted 1 :1 with water. Ex-
posures were from 3 days to 1 wk. Autoradiograms
were developed in Microdol-X and were stained with
Ehrlich's hematoxylin.
Enzymes
Phospholipase C (Sigma Chemical Co., St. Louis,
Mo. ; from Clostridium welchii ; sp act 2.0 U per mg)
was a partially purified enzyme from bacterial culture
medium prepared according to Ellner (9). Further
purification was carried out either by the procedure of
Zwaal et al. (38) or by our own method . In our proce-
dure, 10 mg of PLC were dissolved in 0 .1 M phos-
phate buffer, pH 6.5, and applied to a 1.6 X 90 cm
column of Sephadex G-100 (Pharmacia Fine Chemi-
cals, Inc., Piscataway, N. J.) previously equilibrated
with the same buffer. Fractions of 4.0 ml were eluted
with the phosphate buffer at rates of 20 or 55 ml per h .
There was no significant difference in fractionation
with these two rates. Optical density at 280 nm was
continuously monitored with a double-beam record-
ing spectrophotometer. Samples (10 or 100 µl) of
each fraction were assayed for PLC activity and for
effect on myogenic cells or chondrocytes which had
been in culture for 24 h. Enzymatic activity was
assayed by a procedure similar to that reported by
Mavis et al. (23) . The assay was based on the fact that
PLC releases water-soluble phosphorylcholine from
lecithin. Using phosphatidylcholine labeled only in
the choline moiety, enzymatic activity can be meas-
ured by extracting the water-soluble counts released
by PLC from an ether solution of lecithin . For each
sample to be assayed, 10,ul (10,000 cpm) of [1,2_14C]_
phosphatidylcholine chloride (International Chemi-
cal and Nuclear Corporation, Burbank Calif., sp act
117 mCi per mmol) were dissolved in 2.0 ml of ether
containing 1 .0 mg of unlabeled L-a-lecithin (Sigma
Chemical Co.) as a carrier. The ether solution was
placed in a screw-capped tube containing 0.4 ml of
0.1 M phosphate buffer, pH 7.1 with 1.0 mM CaC12.20 30 40 50 60
Time (min)
FIGURE 1 Kinetics of enzymatic degradation of
[14C]lecithin. Ordinate represents PLC activity mea-
sured as counts per minute remaining in ether phase.
Ether was counted since it was the top phase and a
sample could be collected cleanly without contamina-
tion from the water phase which contained labeled
phosphorylcholine and emulsified undegraded lecithin .
Depicted are the complete reaction_ mixture with 0 .1
mg of commercial PLC (-s-.-), reaction mixture
without PLC (-O---o--), and complete reaction mix-
ture containing 1 .0 mg lysolecithin, an inhibitor of PLC
(. .A. . .A • •). Boiled PLC yielded a curve similar to
that with no enzyme.
To start the reaction, 0 .1 ml of a column fraction was
added and the tube was shaken vigorously at room
temperature for 30 min. The phases were then per-
mitted to separate and 0.5 ml of the ether phase was
counted in 10 ml of scintillation fluid . Preliminary ex-
periments (Fig. 1) demonstrated the usefulness of this
procedure as an assay .
A purified preparation of PLC from B. cereus was a
gift of Dr. L. L. M. van Deenen.
Commercial and purified PLC preparations were
subjected to electrophoresis in 5% polyacrylamide
gels in 1 % sodium dodecyl sulfate according to the
procedure of Maizel (20). PLC preparations were
run on gels 10 cm long at 3 V/cm for 7 h . The gels
were then stained with amido black .
Collagenase (Worthington Biochemical Corp.,
Freehold, N. J.), testicular hyaluronidase (Calbio-
chem, San Diego, Calif.), chondroitinase ABC (Miles
Research Div., Miles Laboratories Inc ., Elkhart,
Ind.), pronase (Calbiochem), phospholipase A
(Sigma Chemical Co. ; from bee venom, 1180 TJ per
mg), and phospholipase D (Sigma Chemical Co . ;
from cabbage, 22 U per mg) were dissolved in BSS
and sterilized by Millipore filtration. These prepara-
tions were diluted into tissue culture medium with no
further purification.
Agarose Coupling of PLC
PLC was attached to agarose beads (Sepharose
4B, Pharmacia Fine Chemicals, Inc .) according to
the procedure of Cuatrecasas (5). 50 mg of PLC were
dissolved in 5.0 ml of 0.1 M phosphate buffer, pH 7.1,
made 50% (vol/vol) with glycerol. This solution was
then added to CNBr-activated agarose beads and was
stirred overnight at 4 °C. The beads were then washed
with the same buffer until no enzymatic activity
could be detected in the washings . Settled, coupled
beads (10 µl) were assayed for PLC activity as de-
scribed above and were found to release as much label
from [14C]lecithin as 20-25 µg of commercial enzyme .
Coupled beads (0.1 ml) were incubated for 16 h at
37.5 °C with 10.0 ml of complete tissue culture me-
dium. The beads were then removed by centrifuga-
tion and the medium was filtered. Myogenic cells
were cultured in this medium . Control media were
either treated with agarose beads which had been
subjected to all steps of the coupling procedure but
without PLC or contained crude PLC but no beads.
Extracellular Matrix Synthesis
Incorporation of [35S]sulfate (Na235SO4, New
England Nuclear, sp act 738 mCi per mmol), into
polysaccharide secreted by chondrocytes was meas-
ured according to previously described procedures
(24, 26) . Labeled sulfate, at a concentration of 5.0 ,uCi
per ml of medium, was added to untreated 6-day-
old cultures ; to cultures which had been exposed to
12.5 or 25.0 µg of PLC per ml for 6 days ; to PLC-
treated cultures 48 h after removal of PLC; and to
PLC-treated cultures which were trypsinized and per-
mitted to grow to confluence in the absence of en-
zyme. The label was present in the medium for a 24-h
period before the cultures were frozen on a dry-ice
acetone mixture. Media and cells with associated
matrix were separately digested with pronase and
precipitated with cold trichloroacetic acid. The
supernatants were exhaustively dialyzed against 0 .01
M sodium sulfate and finally against distilled water.
Samples were counted in a scintillation counter and
were characterized by electrophoresis on cellulose
acetate strips in pyridinium formate buffer (0 .1 M,
pH 3.0, 10 V/cm, 60 min, 25°C) .
RESULTS
Effect of Commercial PLC on
Myogenic Cells
A series of myogenic cell cultures were set up at
an initial density of 0.5 X 106 cells in 1 .5 ml of
medium in 35-mm dishes . The cells were permitted
to attach to the substrate (plasma clot or gelatin)
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109FIGURE 2 Multinucleated myotubes in a control culture (Fig . 2 a). Unfused myogenic cells in PLC
(25 ,ag per ml) (Fig . 2 b). Mitotic figure can be seen in PLC culture (arrow). Both cultures were fixed on
day 4. X 240 .
overnight. The medium was then removed and
fresh medium containing 0, 3, 6, 12 .5, 25, or 50 µg
of commercial PLC was added. Control dishes
received boiled PLC or PLC which had been
dialyzed against BSS. The concentrations of PLC
were kept constant when ever the medium was
changed. By the 3rd day, multinucleated myo-
tubes had formed in cultures containing 0, 3, or 6
µg of PLC and in cultures containing boiled en-
zyme (Fig . 2 a). These cultures were indistin-
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guishable from each other in that there were no
differences in size, number, or degree of multi-
nuclearity of myotubes in any of the concentration
of PLC. In contrast, cultures containing dialyzed
or undialyzed PLC at concentrations of 12, 25, or
50 µg per ml had no myotubes (Fig. 2 b). To
determine if a contaminating protease might have
prevented fusion, myogenic cells were cultured in
medium containing trypsin, pronase, or collagen-
ase at concentrations of 10 and 20 µg per ml .Myotubes formed in these cultures and were
indistinguishable from controls. Similarly, neither
hyaluronidase nor chondroitinase ABC prevented
fusion at concentrations of 10-20 µg per ml.
Neither commercial PLC nor more purified PLC
(see below) had detectable proteolytic activity in
an azoalbumin assay (37) which could detect
trypsin- or pronase-induced proteolysis at enzyme
concentrations of 0.2 µg per ml. Phospholipase A,
at concentrations of 5-50 µg per ml, caused vac-
uolization and death of cells. Phospholipase D had
no effect on fusion up to concentrations of 20-30
µg per ml. At higher concentrations, cells detached
or died.
Mitotic figures were found in all concentrations
of PLC. Cell density (cells per unit area) was
identical in all concentrations of PLC in which
no fusion occurred. PLC-treated cells showed no
tendency to pile up locally, indicating that
motility was not markedly impaired . However,
cells in PLC were, on the average, more spindle
shaped than untreated cells. Multicellular strings
were observed in PLC-treated cultures. Similar
strings are commonly seen in control dishes as an
apparent prelude to fusion. However, since there
is no certain method of identifying nonstriated
myoblasts, it is possible that none of the cells in
the strings were engaged in any prefusion ac-
tivities. In spite of the close contacts between cells
in such strings, no fusion was observed with the
electron microscope (see below) . PLC-treated cells
continued to multiply in the presence of the
enzyme and, by the 4th-5th day, reached con-
fluence and formed multilayers. No myotubes were
observed up to the 12th day in the presence of
PLC. Hence, the effect of the enzyme was not
merely to delay fusion.
With the light microscope it is often difficult to
be certain that cells are fused . Therefore, control
and PLC-treated cultures were fixed with 2 .5%
glutaraldehyde and examined in the electron
microscope (Fig. 3) . Surface membranes of mono-
nucleated cells were closely apposed in PLC-
treated cultures, but no fusion was observed .
Membranes and cytoplasmic organelles in enzyme-
treated cells were indistinguishable from those of
control cells. Many cells in PLC contained
microtubules and intermediate-sized filaments
(11). No thick (150 A) and few thin (60 A) fila-
ments were found upon measuring filament
diameters on micrographs . Controls for measure-
ments were thick and thin filaments found in 6-
day myotubes in untreated cultures.
Reversibility of Fusion Inhibition
A series of cultures were set up in commercial
PLC at a concentration of 25 µg per ml of medium .
On the 3rd, 4th, and 5th days, the PLC medium
was removed and the cells were washed in situ
with BSS. Fresh medium containing no PLC was
then added. At 2-h intervals several cultures were
fixed. Multinucleated myotubes began to appear
8-10 h after removal of enzyme (Fig. 4). Spon-
taneous contractions were observed in these
myotubes by the 12th-18th h . This experiment
demonstrated that the effect of PLC was re-
versible and was not a result of selective killing of
muscle precursor cells in the population . Although
the 8-10-h period corresponds to the time re-
quired for one traverse of the cell cycle (see below,
and reference 3), it may represent the time re-
quired for repair or resynthesis of cell surface
constituents released or damaged by PLC and
may only be fortuitously equal to the cycle time .
PLC and the Cell Cycle
Although mitotic figures were observed in PLC-
treated cultures, it seemed possible that the
enzyme was preferentially blocking cell division
in muscle precursors but not in the "contami-
nating" connective tissue cells in the cultures . If
PLC were acting in this manner, fusion would be
inhibited because of the failure of myoblasts to
enter the Gl phase of the cell cycle or to acquire
the capability to fuse through a critical or quantal
mitosis (3) . The following experiments indicate
that PLC does not act in this way .
[Methyl-8H]thymidine at a concentration of
1 .0 µCi per ml was added to 2-day-old cultures
which had been in commercial PLC (25,ug per ml)
for I day. After a further incubation for 24 h, the
enzyme and labeled thymidine were removed and
the cells were permitted to recover in the presence
of 0.2 mM unlabeled thymidine . After myotubes
had formed, autoradiograms were prepared and
showed that almost all nuclei in myotubes were
labeled (Fig. 5). In a second experiment, cell
cycle times were determined according to con-
ventional techniques (3, 31) . Two series of cultures
were set up. One had 25 µg of PLC per ml; the
other had no PLC. The labeling index (percent of
nuclei incorporating labeled thymidine at zero
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111FIGURE 3 Electron micrographs of PLC-treated (Fig . 8 a) and control myogenic cells (Fig. 3 b) on
day 6. Cells in PLC are in close proximity but surface membranes are intact. Control cells are also in
close proximity but contain myofibrils. Insets are higher power views of membrane regions outlined by
rectangles (arrows). Electron-opaque plaques of unknown significance are visible on the surfaces of
both control and PLC-treated cells. X 9,000. Insets, X 60,000.
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THE JOURNAL OF CELL BIOLOGY • VOLUME 58, 1973FIGURE 4 Myotubes forming in a culture 10 h after recovery from PLC treatment. Day 4. X 240.
FIGURE 5 Labeled nuclei in myotubes recovering from PLC-induced fusion block . Cells were fixed 19 h
after removal of PLC and [3H]thymidine. X 400.
time) was determined for both control and PLC- experiments implied that the inhibition of fusion
treated cultures by counting 1,000 nuclei in each was not a secondary result of alteration of the cell
of four cultures. 32% of control nuclei and 33 % of cycle and that, if a mitosis were required before
PLC-treated nuclei were labeled at the end of a fusion would occur, PLC did not act by stopping
15-min exposure to radioactive thymidine. There- that mitosis.
fore, the same number of cells were in cycle in
PLC-treated cultures as in controls. It is apparent Direct Effect of PLC on Cells
from Fig. 6 that the duration of the cell cycle and
its component phases was unaffected by con-
	
In the experiments described above, PLC was
centrations of PLC which inhibited fusion . These used in medium together with cells. It was pos-
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11.3sible that the enzyme did not act directly on the
cells but rather on some component of the tissue
culture medium. Degradation of a factor required
for fusion (15) or release of an inhibitor from a
component of the medium could lead to the ob-
served failure of myotube formation . Commercial
PLC was therefore coupled to a removable sub-
strate (agarose beads) and was incubated with
complete medium for 16 h . The substrate and at-
tached, active, enzyme were then removed by
centrifugation. Myogenic cells formed myotubes
when cultured in this medium (Fig . 7). It therefore
114
FIGURE 6 Cell cycle determinations for untreated
myogenic cells (-•-•-) and myogenic cells in PLC
(25 µg per m1) (--o--o--) . Curves are identical and
abeling indices (L.I.) were approximately equal.
appeared that PLC was acting directly on the
myogenic cells and presumably on the cell surface .
Effects of Purified PLC
All of the experiments described above were
repeated with purified PLC and the results were
identical to those obtained with commercial PLC .
Both enzymatic activity and fusion inhibition were
followed at each stage of purification. An example
is shown in Fig. 8 which depicts optical density,
PLC activity, and fusion inhibition as functions of
fraction number from the chromatography of
partially purified PLC on Sephadex G-100 . It can
be seen that PLC activity and fusion inhibition
ran together on the column . The enzyme ap-
parently represented approximately 5 % of the
total protein in the commercial preparation as
measured by the procedure of Lowry et al . (19).
Approximately 0.5µg of the purified material
were sufficient to inhibit fusion in cultures con-
taining 1 .5 ml of medium. Upon SDS-poly-
acrylamide electrophoresis, the purified material
displayed one band (Fig . 9). In the absence of
serum in the tissue culture medium, cells in PLC
began to leak intracellular protein after about 1-2
h. Transfer to serum-containing medium led to
recovery but only if transfer was accomplished in
less than 4 h. Apparently there is some factor in
serum which either protects the cells from the lytic
FIGURE 7 Myotubes which formed in medium treated with PLC coupled to agarose beads . X 240.
THE JOURNAL OF CELL BIOLOGY . VOLUME 58, 1973effects of PLC or is, perhaps, a substrate for the
enzyme so that the effective dose which the cells
"see" may be much lower than the actual amount
of material placed into the medium. PLC from
B. cereus which was active as a lipase in our assay
had no effect on fusion over a range of concen-
trations from 0.1 to 10 µg per ml of medium .
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FIGURE 8 Chromatography of 10 mg of commercial
PLC on Sephadex G-100. Represented are optical den-
sity at 280 ram (solid line) and PLC activity (dashed
line) . Inhibition of fusion of myoblasts and inhibition
of matrix synthesis by chondrocytes were observed only
in fractions with PLC activity . In all column runs a
small peak of optical density was observed in the region
with enzymatic activity.
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Effect of PLC on Chondrocytes
Chondrocytes were grown in 12 .5 or 25 µg of
commercial PLC per ml. As with myogenic cells,
chondrocytes multiplied and migrated in the
presence of the enzyme . When both control and
PLC-treated cultures had reached confluence and
controls had deposited extracellular matrix (Fig.
10 a), cultures were fixed and stained with tolui-
dine blue. PLC-treated chondrocytes failed to
deposit metachromatic matrix material (Fig. 10 b).
PLC was removed from the medium and the cells
were permitted to remain in culture for up to 6
days more. Again no metachromatic matrix was
observed. Confluent PLC-treated chondrocytes
were subcultured and allowed to grow to con-
fluence again, but no cartilage matrix was de-
tected. Incorporation of [85S]sulfate into polysac-
charide was markedly inhibited in PLC-treated
and recovered cells (Table I). Electrophoresis of
sulfated polysaccharide from enzyme-treated cul-
tures showed little if any synthesis of chondroitin
sulfate (Fig. 11). Both cells and medium were
assayed to rule out the possibility that cells which
did not stain metachromatically might have
synthesized matrix materials but were unable to
deposit them in an insoluble extracellular struc-
ture.
DISCUSSION
It is apparent that PLC selectively and reversibly
inhibits fusion of myoblasts . PLC also inhibits
FIGURE 9 Polyacrylamide gels stained with amido black and cleared in 7% acetic acid . Gel A contained
crude PLC and showed at least six bands . Gel B contained PLC fraction from G-100 column illustrated
in Fig. 8. Only one band was seen . This band corresponded to the farthest migrating (lowest molecular
weight) band of the crude enzyme . Arrow indicates direction of migration.
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115FIGURE 10 Control chondrocytes on day 7 in culture, stained with toluidine blue, (Fig. 10 a). Most cells
are surrounded by metachromatic capsules . In PLC, (Fig. 10 b), chondrocytes showed no metachromatic
capsules and were stellate or "fibroblastic" in morphology . Mitotic figures were observed in treated
cultures (arrow). X 400.
cartilage matrix synthesis by chondrocytes . In
	
TABLE I
both instances the biological effect of PLC is
	
Effect of PLC on Incorporation of Labeled Sulfate
specific in the sense that neither cell division nor
	
by Chondrocytes
cell motility is significantly impaired while the
differentiated functions of the two cell types are
suppressed. Obviously, then, the cells can make
new surface membrane in the presence of the
enzyme and can engage in whatever surface
activities are required for movement . The mech-
anism by which PLC exerts its specific anti-
differentiation effects is not known. To rationalize
our experimental observations we are considering
the following hypothesis: PLC alters the surfaces of
myoblasts and chondrocytes in such a way that
cell recognition phenomena fail to occur . Given a
failure in recognition, the processes leading to
fusion and contractile protein synthesis by myo-
blasts or to extracellular matrix synthesis by
chondrocytes do not occur in spite of close surface-
to-surface apposition.
Other hypotheses concerning the mechanism of
differentiation inhibition could, of course, be
constructed. We have assumed that PLC does not
enter cells (at least in an active form) but we are
exploring the alternative possibility. PLC might
act to stimulate cell division and keep cells from
withdrawing from the mitotic cycle . Under such
circumstances myoblasts might not fuse (3) and
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chondrocytes might not synthesize matrix com-
ponents (24). The enzyme could be exerting dif-
ferent types of effects on different kinds of cells .
Sulfate transport systems in chondrocyte surfaces
could be impaired so that chondroitin sulfate
synthesis would not occur, while some other
myoblast property, unrelated to ion transport,
could be altered. PLC might stimulate rapid
membrane turnover or repair so that cells divert
metabolites normally used in surface differentia-
tions to pathways for basic membrane structures .
Since PLC removes phosphorylamines from leci-
thins, residual diglycerides in the surface mem-
branes could be responsible for the antidifferentia-
tion effects (22) . However, no large osmiophilic
cpm 86S in
Polysaccharide
Cells
Control 15,730
PLC-treated 3,860
Medium
From control cells 14,660
From PLC-treated cells 5,400cm
FIGURE 11 Electrophoresis of sulfated polysaccharide
extracted from control (solid line) and PLC-treated
chondrocytes (dashed line) . Polysaccharide from the
medium gave similar results . Superimposed is an elec-
trophoresis pattern of a mixture of hyaluronic acid (HA)
and chondroitin sulfate (CS) which served as standards.
droplets were found in electron micrographs of
PLC-treated cells. The small, dense, plaques
described in Fig. 3 were observed in both control
and treated cells. PLC might attach to the surfaces
of myoblasts and cover or shield sites which are
active in fusion. This possibility is under study.
The enzyme could alter membrane lipids such that
certain proteins would not function properly (6,
23) or would be released from the membrane (see
however, reference 17) . We are at present testing
this last hypothesis and have found that PLC
releases acid-precipitable radioactivity from the
surfaces of cells which have been labeled with
1251 by the lactoperoxidase procedure (10, 21, 30) .
We are attempting to characterize the released
material both biochemically and biologically. In
this regard, it is interesting to note that Lesseps
(18) has reported that, of a variety of enzymes,
only PLC removed the lanthanum-staining "coat"
from embryonic chick cells . It is also possible that
the lipase activity of our purified PLC preparation
is not responsible for the observed biological
effects. In spite of our purification procedure,
another activity of the same molecule or of an
unseparated contaminant molecule could be the
inhibitor of differentiation . With regard to this
possibility, purified PLC from B. cereus was active
as a lipase in our assay but had no effect on fusion
or synthesis of cartilage matrix . However, even if
the bacillus enzyme is a purer preparation, it is
also a different protein with somewhat different
substrate specificities (33) compared to clostridial
PLC. In the light of these considerations, the
results of our experiment with PLC coupled to
agarose beads could be explained in another way .
A contaminating molecule could have been
structurally altered during coupling and hence
rendered inactive (or it might not have been
coupled). Alternatively, if the antidifferentiation
activity is a property of the PLC molecule, then
that activity might have been abolished during
coupling, while the lipase activity survived.
The dose-response curve relating fusion to
concentration of PLC showed an apparent "all-
or-none" effect. This result might be due to the
difficulty in accurately quantitating fusion with
the light microscope. It is also possible that a fine-
grained analysis might reveal a graded decrease in
number of fused cells between the doses of 6 and
10 µg of commercial PLC (0.3 and 0.5 µg of
purified PLC) . In view of our ignorance about
the mechanism of action of PLC, the all-or-none
response remains noteworthy but unexplained .
In many respects the antidifferentiation prop-
erties of PLC are similar to those of 5-bromodeoxy-
uridine (BUdR; 1, 4, 36). PLC and BUdR effects
on myoblasts are readily reversible while the
effects of these substances on chondrocytes are not
easily reversible. PLC, however, does not alter
cell morphology to the extent that BUdR does .
In PLC, cells are stellate or spindle-shaped but
are not as spread out as cells in BUdR. In pre-
liminary experiments we have found that PLC
and BUdR release the same types of 'III-labeled
proteins from the cell surface . Since BUdR affects
the surface properties of chondrocytes (1), it is
possible that the antidifferentiation effects of
PLC and BUdR result from a common mechanism
involving the loss of specific molecules from the cell
surface.
In other systems, phospholipases of various types
prevent virus-induced cell fusions (2, 12, 13) or
may promote fusion of polycation-aggregated cells
(8) . The specific mechanisms operating to inhibit
or induce fusion in those systems is not clear.
Study of the mechanism of PLC action in our
system may enable us to dissect some of the events
both in the differentiation of specific cell surface
function and in the control of expression of dif-
ferentiation which may reside in the surface
membrane.
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